# A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus

> **NCT07538154** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Sinocelltech Ltd.** · enrollment: 159 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **BIOLOGICAL:** SCTC21C

## Key facts

- **NCT ID:** NCT07538154
- **Lead sponsor:** Sinocelltech Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-04
- **Final completion:** 2028-04
- **Target enrollment:** 159 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07538154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07538154, "A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07538154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*